Enanta Pharmaceuticals (ENTA) logo

ENTA earnings date, and what happened the last 4 times

After the close, in 79 days. Expected: the company has not confirmed it. ENTA closed higher after 1 of its last 4 reports.

Next report: Mon Feb 8, expected
Quality Score: -10, Poor
After a report: -6.1%, average close

The moment ENTA reports

  • Its figures, in plain words
  • How it moves after, beside its last four
  • Its Quality Score going in, and after

See it live, free until Tuesday morning. No account. No card.One stock in full, free. No account.$1 for a first month of Pro. Then $39 a month. Then keep going with a free account.Then $1 for a first month of Pro.Then 7 days of Pro free, with a card.

What ENTA reported on Nov 16, 2026

Sales of $12.9M, 15% less than a year ago; a loss of $0.81 a share, from $0.87.

For the quarter that ended Sep 30, 2026, from the company's results release of Nov 16, 2026. SEC filing

What happened after ENTA's last 4 reports

ENTA's last 4 earnings reports
ReportedScore
in
Reaction
Nov 16, 2026After closenone-18.6%Gap -3.9%
Aug 10, 2026After closenone-2.1%Gap -0.5%
May 11, 2026After closenone-6.0%Gap -5.6%
Feb 9, 2026After closenone+2.2%Gap +9.3%

Across these 4 reports ENTA opened higher after 1 of 4 and closed higher after 1 of 4; on average it opened -0.2%, closed -6.1%, and stood -6.6% five sessions on.

Gap: where the stock opened the session after the report. Reaction: where that session closed. Both against the close before the report. The largest of the 4: -18.6% after the Nov 16, 2026 report.

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

Pro members see ENTA's reaction live as a report comes out, the release line by line with the outlook it gave, and an optional alert before it reports.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Questions about ENTA's earnings

As of Nov 21, 2026: Enanta Pharmaceuticals (ENTA): expected to report Mon Feb 8, after the close. ENTA closed higher after 1 of its last 4 reports. Its Quality Score is -10 (Poor). Scores as of 8:56 PM ET, 15 minutes behind.

When is ENTA's next earnings date?

Expected to report Mon Feb 8, after the close, a date Breakaway expects from the company's usual timing; the company has not confirmed it. ENTA closed higher after 1 of its last 4 reports. Past behavior, not a forecast.

What did ENTA report last quarter?

ENTA reported on Nov 16, 2026, for the quarter that ended Sep 30, 2026: sales of $12.9M, 15% less than a year ago; a loss of $0.81 a share, from $0.87.

Does ENTA report before or after the market?

ENTA is expected to report Mon Feb 8, after the close. Its last 4 reports came after the close.

How did ENTA stock react to its last earnings report?

Nov 16, 2026, after the close: the next session ENTA opened -3.9% and closed -18.6%.

Does ENTA stock usually go up after earnings?

ENTA closed higher after 1 of its last 4 reports. On average it closed -6.1% the session after a report, after opening -0.2%. Past behavior, not a forecast.

Enanta Pharmaceuticals' page has its Quality Score, its chart, and its insiders' trades. Who reports this week: the earnings calendar.

Every report, ranked.

Every company reporting, sorted by Quality Score, each report's move as it comes in, real-time prices, and optional alerts before a report.

See every stock reporting this weekSee every stock reporting this weekStart Pro

See it live, free until Tuesday morning. No account. No card.One stock in full, free. No account.$1 for a first month of Pro. Then $39 a month. Then keep going with a free account.Then $1 for a first month of Pro.Then 7 days of Pro free, with a card.

Past behavior, not a forecast. The score is delayed at least 15 minutes; the reports' moves are as they closed.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs. Recorded live since Sep 9, 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.